Culwell Kelly 4
4 · Evofem Biosciences, Inc. · Filed May 8, 2020
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2020-05-06$5.24/sh−7,792$40,830→ 186,434 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction.